Airway Therapeutics
- Website
- airwaytherapeutics.com
- Total Funding
- $50.0M
- Last Round
- $50.0M Venture RoundAug 2026
- Rounds
- 1
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
About
Airway Therapeutics is developing immune-modulating therapies for respiratory, inflammatory, and infectious diseases. Its first-in-class biologic, zelpultide alfa, is a recombinant protein designed to replicate native surfactant protein D. The company says zelpultide alfa is intended to modulate immune responses, reduce inflammation, and enhance infection clearance across acute and chronic conditions.
Summary
Airway Therapeutics is a Biotech company. It has raised $50.0M in total across 1 round, most recently a $50.0M Venture Round in Aug 2026.
Funding History
Aug 2026
Similar Companies
Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...
Abogen Biosciences develops RNA therapeutics using integrated mRNA design, lipid nanoparticle del...
Late-stage biopharma using single-molecule tracking, AI, and engineering to discover and develop ...
Xaira Therapeutics is an integrated biotechnology company driving advances in artificial intellig...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/airway-therapeutics"><img src="https://indexed.vc/api/badge/company/airway-therapeutics" alt="Airway Therapeutics on Indexed.vc" width="260" height="76" /></a>